France· FR:67099299
FORTACIN 150 mg/ml / 50 mg/ml, spray cutané,solution
A medicinal product containing lidocaïne + prilocaïne, registered in France by RECORDATI IRELAND.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- LIDOCAÏNE + PRILOCAÏNE
- Manufacturer
- RECORDATI IRELAND
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009300736501 flacon(s) pulvérisateur(s) aluminium de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocaïne + prilocaïne in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAnesdermInPharm Sp. z o.o.
- United StatesCadira Compliant Blood StatAsclemed USA, Inc.
- United KingdomDenela 5% creamTeva UK Ltd
- SwitzerlandAnesderm
- CzechiaEMLAAspen Pharma Trading Limited, Dublin
- FinlandEmlaOrifarm Oy
- SwedenEMLA 25 mg/25 mg Medicinskt plåsterAspen Pharma Trading Limited
- SpainANAMAP 25 MG/G + 25 MG/G CREMAGlenmark Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emla, Emla Pflaster
- Belgium · Emla, Emla Patch
- Cyprus · Emla, Xylocream
- Czechia · Emla
- Germany · Anesderm, Emla
- Denmark · Emla, Lidocain/Prilocain Idd
- Estonia · Nulbia
- Spain · Anamap®, Anestderma
- Finland · Emla, Oraqix
- United Kingdom (Northern Ireland) · Emla, Nulbia
- Greece · Emla, Nulbia
- Hungary · Li-Pri
- Ireland · Emla, Oraqix
- Iceland · Emla, Fortacin
- Italy · Emla, Lidocaina E Prilocaina Teva
- Liechtenstein · Fortacin
- Luxembourg · Emla, Emla Patch
- Malta · Emla, Opralix
- Netherlands · Emla, Lidocaïne/Prilocaïne Teva
- Norway · Emla, Fortacin
- Poland · Anesderm, Emla
- Portugal · Emla, Emla Penso
- Romania · Romla
- Sweden · Emla, Oraqix
- Slovakia · Romla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d15b54de-e267-42be-bccf-136235c8241a GET /v1/drugs/d15b54de-e267-42be-bccf-136235c8241a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67099299",
"date_amm": "2013-11-15",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/881",
"substance": "LIDOCAÏNE + PRILOCAÏNE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour pulvérisation",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about lidocaïne + prilocaïne.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.